Center For Translational Research In Neurodegenerative Disease

Dr. Paramita Chakrabarty’s research investigates the role of neuroinflammation in Alzheimer’s disease.

The McKnight Brain Institute’s signature programs in neurological diseases include ALS, Alzheimer’s disease, brain tumor immunotherapy, and Parkinson’s disease, as well as other neurodegenerative disorders. The MBI is dedicated to accelerating discoveries in these fields to enhance brain health and develop innovative therapies. 1Florida Alzheimer’s Disease Research Center (1Florida…

The McKnight Brain Institute’s signature programs in cognition, behavior, and sensation include age-related cognitive decline, developmental disorders, pain, sensory dysfunction, and substance use disorders and other neuropsychiatric diseases. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies. Center for Addiction Research & Education…

The McKnight Brain Institute’s signature programs in acquired neural injury include neural control of respiration, spinal cord injury, stroke, and traumatic brain injury. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies. Brain Injury, Rehabilitation, and Neuroresilience Center (BRAIN) BRAIN Center…

Gene-editing study provides insight into mechanisms of how two proteins may accumulate in familial Parkinson’s disease.

Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.

New mouse model expresses low levels of a mutant form of tau, a protein associated with Alzheimer’s disease and related dementias.

UF neuroscientists author review examining latest evidence for disease process, risk factors for Parkinson’s.

Aligning Sciences Across Parkinson’s (ASAP) accelerates research efforts into underlying causes of disease.

Neuroimmunologist Dr. Malú Tansey is highlighted in Knowable Magazine.